Document Detail


Role of infarction artery status in left ventricular remodeling after acute myocardial infarction.
MedLine Citation:
PMID:  9158174     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
The aim of this study was to evaluate the relation between the infarction artery status and left ventricular volumes, independently of regional ventricular dysfunction, at 4-6 weeks after a first myocardial infarction. The study group consisted of 100 patients, of whom 80 received thrombolytic treatment. Coronary and contrast left ventricular angiograms were performed at 36+/-5 days postinfarction. Left ventricular end-diastolic and end-systolic volumes were measured. The centerline chord motion method was used to calculate the extent of wall motion abnormality (percentage of chords with hypokinetic motion) and its severity (maximum units of S.D. below the normal wall motion reference). Minimum lumen diameter, patency and collateral flow in the infarction artery were also analyzed. Eight patients (group I) showed occlusion with poor collateral flow in the infarction artery, 22 patients (group II) occlusion with good collateral flow, 38 patients (group III) severe residual stenosis (minimum lumen diameter < or = 1 mm), and 32 patients (group IV) non-severe residual stenosis (minimum lumen diameter > 1 mm). Patients from group I presented greater wall motion abnormality in terms of both extent (P=0.005) and severity (P=0.007), and greater end-diastolic (P=0.07) and end-systolic (P=0.0008) volumes; there were no differences among groups II, III and IV. By stepwise multivariate regression analysis, the extent of wall motion abnormality was the main determinant of end-diastolic (P=0.0001) and end-systolic (P=0.0001) volumes; occlusion with poor collateral flow was also a significant independent factor for end-systolic volume (P=0.03). Total occlusion (including both with and without collaterals) and the minimum lumen diameter did not correlate with end-diastolic and end-systolic volumes. We concluded that (A) the extent of regional dysfunction is the primary determinant of left ventricular volumes at 4-6 weeks postinfarction. (B) The status of the infarction artery is a weak predictor of end-diastolic volume, which is the best descriptor of ventricular remodeling, although occlusion with poor collateral flow is associated to larger end-systolic volume.
Authors:
J Sanchis; L Insa; V Bodí; S Egea; J V Monmeneu; F J Chorro; A Llácer; V López Merino
Related Documents :
17597524 - The effect of electrical neurostimulation on collateral perfusion during acute coronary...
718574 - Regional coronary blood flow at rest and during high sustained +gz in a miniature swine...
15721104 - Comparison of the cardioprotective effect of prodromal angina pectoris and collateral c...
3776674 - Relationships between coronary artery obstruction, asynergy, presence of collaterals an...
14729404 - Temporal changes in matrix metalloproteinase expression and inflammatory response assoc...
3698244 - Relationship of angiographically defined coronary artery disease to serum lipoproteins ...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  International journal of cardiology     Volume:  59     ISSN:  0167-5273     ISO Abbreviation:  Int. J. Cardiol.     Publication Date:  1997 Apr 
Date Detail:
Created Date:  1997-06-10     Completed Date:  1997-06-10     Revised Date:  2006-07-12    
Medline Journal Info:
Nlm Unique ID:  8200291     Medline TA:  Int J Cardiol     Country:  IRELAND    
Other Details:
Languages:  eng     Pagination:  189-95     Citation Subset:  IM    
Affiliation:
Cardiology Department, University Clinic Hospital, Valencia, Spain.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Cardiac Volume*
Collateral Circulation
Coronary Angiography
Coronary Circulation
Coronary Disease / pathology,  physiopathology
Coronary Vessels / pathology,  physiopathology*
Diastole
Forecasting
Heart Ventricles / pathology,  physiopathology
Humans
Middle Aged
Multivariate Analysis
Myocardial Contraction
Myocardial Infarction / drug therapy,  pathology,  physiopathology*
Plasminogen Activators / therapeutic use
Regression Analysis
Systole
Thrombolytic Therapy
Tissue Plasminogen Activator / therapeutic use
Vascular Patency
Ventricular Dysfunction, Left / pathology,  physiopathology
Ventricular Function, Left*
Chemical
Reg. No./Substance:
EC 3.4.21.-/Plasminogen Activators; EC 3.4.21.68/Tissue Plasminogen Activator

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Salt intake and blood pressure in Nigerian hypertensive patients.
Next Document:  Unusual presentation of an atrial septal aneurysm with left atrial myxoma: a case report.